Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B J Materson

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Archives of Internal Medicine|October 10, 1994
Isolated systolic hypertension. Another disincentive to treatment is removedB J Materson
The American Journal of Medicine|October 5, 1984
Monotherapy of hypertension with angiotensin-converting enzyme inhibitorsB J Materson
Journal of the National Medical Association|May 1, 1985
Black/white differences in response to antihypertensive therapyB J Materson
Cardiology Clinics|February 1, 1986
Adverse effects of antihypertensive treatmentB J Materson
Archives of Internal Medicine|February 12, 1996
ACE inhibitors as a shield against diabetic nephropathyB J Materson
The American Journal of Cardiology|April 2, 1992
Adverse effects of angiotensin-converting enzyme inhibitors in antihypertensive therapy with focus on quinaprilB J Materson
The Alabama Journal of Medical Sciences|January 1, 1980
Complicated hypertensionB J Materson
American Journal of Hypertension|August 26, 1998
Disease management, pharmacoeconomics, and molecular biology: tools for prevention of hypertensive complicationsB J Materson
American Journal of Hypertension|August 26, 1998
Will angiotensin converting enzyme genotype, receptor mutation identification, and other miracles of molecular biology permit reduction of NNT?B J Materson
The Journal of the Florida Medical Association|June 1, 1971
Generalized burning paresthesia due to intravenous furosemideB J Materson
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Archives of Internal Medicine|October 10, 1994
Isolated systolic hypertension. Another disincentive to treatment is removedB J Materson
The American Journal of Medicine|October 5, 1984
Monotherapy of hypertension with angiotensin-converting enzyme inhibitorsB J Materson
Journal of the National Medical Association|May 1, 1985
Black/white differences in response to antihypertensive therapyB J Materson
Cardiology Clinics|February 1, 1986
Adverse effects of antihypertensive treatmentB J Materson
Archives of Internal Medicine|February 12, 1996
ACE inhibitors as a shield against diabetic nephropathyB J Materson
The American Journal of Cardiology|April 2, 1992
Adverse effects of angiotensin-converting enzyme inhibitors in antihypertensive therapy with focus on quinaprilB J Materson
The Alabama Journal of Medical Sciences|January 1, 1980
Complicated hypertensionB J Materson
American Journal of Hypertension|August 26, 1998
Disease management, pharmacoeconomics, and molecular biology: tools for prevention of hypertensive complicationsB J Materson
American Journal of Hypertension|August 26, 1998
Will angiotensin converting enzyme genotype, receptor mutation identification, and other miracles of molecular biology permit reduction of NNT?B J Materson
The Journal of the Florida Medical Association|June 1, 1971
Generalized burning paresthesia due to intravenous furosemideB J Materson
Pageof 10